- Home
- ICCC vs EDRY Comparison
ICCC vs EDRY Comparison
Compare ICCC & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- EDRY
- Stock Information
- Founded
- ICCC 1982
- EDRY 2018
- Country
- ICCC United States
- EDRY Greece
- Employees
- ICCC N/A
- EDRY N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- ICCC Health Care
- EDRY Consumer Discretionary
- Exchange
- ICCC Nasdaq
- EDRY Nasdaq
- Market Cap
- ICCC 39.2M
- EDRY 31.7M
- IPO Year
- ICCC 1987
- EDRY N/A
- Fundamental
- Price
- ICCC $4.94
- EDRY $10.98
- Analyst Decision
- ICCC
- EDRY
- Analyst Count
- ICCC 0
- EDRY 0
- Target Price
- ICCC N/A
- EDRY N/A
- AVG Volume (30 Days)
- ICCC 10.9K
- EDRY 5.8K
- Earning Date
- ICCC 05-13-2025
- EDRY 05-20-2025
- Dividend Yield
- ICCC N/A
- EDRY N/A
- EPS Growth
- ICCC N/A
- EDRY N/A
- EPS
- ICCC N/A
- EDRY N/A
- Revenue
- ICCC $26,493,000.00
- EDRY $61,083,227.00
- Revenue This Year
- ICCC N/A
- EDRY N/A
- Revenue Next Year
- ICCC N/A
- EDRY $27.93
- P/E Ratio
- ICCC N/A
- EDRY N/A
- Revenue Growth
- ICCC 51.63
- EDRY 28.35
- 52 Week Low
- ICCC $3.34
- EDRY $10.04
- 52 Week High
- ICCC $5.82
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- ICCC 48.48
- EDRY 49.31
- Support Level
- ICCC $4.56
- EDRY $11.05
- Resistance Level
- ICCC $5.05
- EDRY $11.38
- Average True Range (ATR)
- ICCC 0.23
- EDRY 0.33
- MACD
- ICCC 0.01
- EDRY 0.03
- Stochastic Oscillator
- ICCC 80.51
- EDRY 29.11
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.